While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate. The post Ocugen's Recent Vaccine Efficacy Results Should Ha
New York, New York--(Newsfile Corp. - July 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Oc
NEW YORK, July 10, 2021 /PRNewswire/ -- WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021 and June
NEW YORK, July 10, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN).  Such investors are advised to con
New York, New York--(Newsfile Corp. - July 9, 2021) - To: All persons or entities who purchased or otherwise acquired securities of Ocugen, Inc. ("Ocugen") (NASDAQ: OCGN) between February 2, 2021 and

Why Shares of Ocugen Are Dropping Today

05:11pm, Friday, 09'th Jul 2021
Investors may be getting concerned about how long it may take for COVID-19 vaccine Covaxin to get approved.
Los Angeles, California--(Newsfile Corp. - July 8, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocugen
Stock markets moved slightly higher despite general worries.
New York, New York--(Newsfile Corp. - July 7, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of O
BENSALEM, Pa., July 7, 2021 /PRNewswire/ --Law Offices of Howard G.
These seven meme stocks to buy could be good picks for July as investor interest in these high-risk, high-return plays continues to grow. The post 7 Meme Stocks to Buy for Their ‘To-the-Moon' Potent
Ocugen Inc. (NASDAQ: OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner Bharat Biotech reported Phase 3 results demonstrating 77.8% p
OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward. The post 3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory appeared
Ocugen's Indian vaccine development partner reported better-than-expected results from its local Covid-19 vaccine trials. OCGN stock has been on a roller-coaster ride on every Covaxin rumor and news i
Armed with new data from its development partner Bharat Biotech, Ocugen Inc (NASDAQ: OCGN) plans to press ahead with plans to file for approval of their COVID-19 vaccine, Covaxin, in the U.S. and C
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE